Erik Söderlind

Active 1996–2014

Affiliations
AstraZeneca (Sweden)This corpus build does not record the country of an author's affiliations, so none is shown here. It does not mean these institutions have no country.
7
Papers
927
Citations
7
h-index
7
i10-index

Self-citations are included in these numbers.

Citations per year

Citations

Citations per year for Erik Söderlind1998: 4 citations1999: 2 citations2000: 2 citations2001: 6 citations2002: 4 citations2003: 1 citations2004: 2 citations2005: 7 citations2007: 9 citations2008: 4 citations2009: 7 citations2010: 10 citations2011: 13 citations2012: 8 citations2013: 12 citations2014: 11 citations2015: 11 citations2016: 15 citations2017: 3 citations2018: 7 citations2019: 30 citations2020: 36 citations2021: 34 citations2022: 12 citations2023: 12 citations2024: 19 citations2025: 4 citations2006: no citations, so this year is not shown

Citation sources

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Fields

  • Pharmacology, Toxicology and Pharmaceutics45.7%
  • Materials Science23.2%
  • Medicine12.2%
  • Biochemistry, Genetics and Molecular Biology7.9%
  • Agricultural and Biological Sciences2.8%
  • Chemistry2.8%
  • Other5.5%

Topics

  • Drug Solubulity and Delivery Systems27.9%
  • Advanced Drug Delivery Systems10.4%
  • Dendrimers and Hyperbranched Polymers10%
  • Crystallization and Solubility Studies7.9%
  • Gastrointestinal motility and disorders6.9%
  • RNA Interference and Gene Delivery5.8%
  • Other31.2%

Frequent coauthors

All papers

Loading papers…